MedTrace Logo

Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension

NCT01673373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2020-11-20

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.

Conditions

  • Renal Artery Stenosis
  • Hypertension, Renovascular

Interventions

DEVICE

iCAST™ Rx Stent System

All enrolled subjects will undergo primary stenting of the target lesion(s) by placement of the iCAST™ RX Stent System.

Sponsors & Collaborators

  • Atrium Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Ken Rosenfield, MD · Massachusetts General Hospital

  • Gary Ansel, MD · OhioHealth Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-23
Primary Completion
2018-06-27
Completion
2020-10-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01673373 on ClinicalTrials.gov